<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.2-a.5'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//ph-ksp.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://ph-ksp.com/a-familiar-drug-in-unfamiliar-territory-will-we-manage-to-repurpose-sglt2-inhibitors-in-pulmonary-arterial-hypertension-journal-of-heart-and-lung-transplant-september-3-2026/</loc>
  <lastmod>2026-09-05T10:13:53Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>A familiar drug in unfamiliar territory: Will we manage to repurpose SGLT2 inhibitors in pulmonary arterial hypertension?, Journal of Heart and Lung Transplant, September 3, 2026</news:title>
   <news:publication_date>2026-09-05T10:13:51Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/reduced-brain-blood-flow-heart-strain-and-cognitive-symptoms-in-pulmonary-arterial-hypertension-therapeutic-advances-in-respiratory-diseases-jan-dec-2026/</loc>
  <lastmod>2026-09-05T09:08:40Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Reduced brain blood flow, heart strain, and cognitive symptoms in pulmonary arterial hypertension, Therapeutic Advances in Respiratory Diseases, Jan-Dec 2026</news:title>
   <news:publication_date>2026-09-05T09:06:27Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>